Literature DB >> 10919568

Engineering of human vascular aortic tissue based on a xenogeneic starter matrix.

A Bader1, G Steinhoff, K Strobl, T Schilling, G Brandes, H Mertsching, D Tsikas, J Froelich, A Haverich.   

Abstract

BACKGROUND: The goal for tissue engineering of vascular grafts is the replacement of a diseased vessel with a functional and stable graft. We now introduce a new concept for the tissue engineering of vessels. The idea was to humanize a previously acellularized, but structurally intact, xenogeneic vessel by repopulation with human autologous cells. To this purpose, a gentle nondenaturing and nondeterging acellularization procedure for xenogeneic aortas was developed. This structure was reseeded with pre-expanded peripheral vascular endothelial cells (EC) and myofibroblasts using specifically designed bioreactors.
METHODS: Aortas from 15-30 kg female landrace pigs were acelullarized with a 0.1% trypsin solution for between 24 and 96 hr. Human vascular cells were harvested from saphenous vein biopsy specimens. Acellularized vessels were reseeded with EC and myofibroblasts. Cell viability after reseeding was assayed by fluorescence staining. Morphologic features of the acellularized matrix and tissue engineered vessel was assayed by transmission and scanning electron microscopy and histologic analysis. Nitric oxide-synthetase activity was investigated by mass spectrometric analysis of bioreactor supernatants. The in vivo immune response was tested by subcutaneous implantation of acellularized porcine aortic tissue in a rat model.
RESULTS: The acellularization procedure resulted in an almost complete removal of the original resident cells, and the 3-D matrix was loosened at interfibrillar zones. However, the 3-D arrangement of the matrix fibers was grossly maintained. The 3-D matrix was covered with a fully confluent human endothelial cell layer obtained by continuous stress challenge in the bioreactor. Myofibroblasts migrated into positions formerly occupied by the xenogeneic cells. Nitric oxide synthetase activity was maintained in the bioartificial graft. T-lymphocyte and CD18 positive leukocyte infiltrate were greatly reduced after acellularization of porcine aortic specimens after implantation in the rat.
CONCLUSIONS: Porcine vessels were acellularized and consecutively fully repopulated with human EC and myofibroblasts. This approach may eventually lead to the engineering of vessels immunologically acceptable to the host using a relatively short preparation period of 2-3 weeks. We expect matrix turnover in vivo leading to a gradual assimilation of the matrix structure by the host mediated by the hosts autologous cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919568

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  23 in total

Review 1.  Engineering of bypass conduits to improve patency.

Authors:  S T Rashid; H J Salacinski; B J Fuller; G Hamilton; A M Seifalian
Journal:  Cell Prolif       Date:  2004-10       Impact factor: 6.831

2.  Hair follicle-derived smooth muscle cells and small intestinal submucosa for engineering mechanically robust and vasoreactive vascular media.

Authors:  Hao-Fan Peng; Jin Yu Liu; Stelios T Andreadis; Daniel D Swartz
Journal:  Tissue Eng Part A       Date:  2011-01-16       Impact factor: 3.845

3.  Composite fibrin scaffolds increase mechanical strength and preserve contractility of tissue engineered blood vessels.

Authors:  Lan Yao; Jinyu Liu; Stelios T Andreadis
Journal:  Pharm Res       Date:  2007-12-19       Impact factor: 4.200

Review 4.  Stem cell sources for vascular tissue engineering and regeneration.

Authors:  Vivek K Bajpai; Stelios T Andreadis
Journal:  Tissue Eng Part B Rev       Date:  2012-07-03       Impact factor: 6.389

Review 5.  [Cell sources for cardiovascular tissue engineering].

Authors:  C Klopsch; P Donndorf; A Kaminski; N Ma; G Steinhoff
Journal:  Chirurg       Date:  2011-04       Impact factor: 0.955

6.  Effects of perfusion and cyclic compression on in vitro tissue engineered meniscus implants.

Authors:  M Petri; K Ufer; I Toma; C Becher; E Liodakis; S Brand; P Haas; C Liu; B Richter; C Haasper; G von Lewinski; M Jagodzinski
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-07-13       Impact factor: 4.342

7.  Small-diameter blood vessels engineered with bone marrow-derived cells.

Authors:  Seung-Woo Cho; Sang Hyun Lim; Il-Kwon Kim; Yoo Sun Hong; Sang-Soo Kim; Kyung Jong Yoo; Hyun-Young Park; Yangsoo Jang; Byung Chul Chang; Cha Yong Choi; Ki-Chul Hwang; Byung-Soo Kim
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

8.  Using a type 1 collagen-based system to understand cell-scaffold interactions and to deliver chimeric collagen-binding growth factors for vascular tissue engineering.

Authors:  Yonggang Pang; Howard P Greisler
Journal:  J Investig Med       Date:  2010-10       Impact factor: 2.895

Review 9.  [Tissue engineering for heart valves and vascular grafts].

Authors:  O E Teebken; M Wilhelmi; A Haverich
Journal:  Chirurg       Date:  2005-05       Impact factor: 0.955

10.  Form Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering.

Authors:  Dan T Simionescu; Joseph Chen; Michael Jaeggli; Bo Wang; Jun Liao
Journal:  J Healthc Eng       Date:  2012-06       Impact factor: 2.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.